These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 28376502

  • 1. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M, Iinuma H, Yagi T, Matsuda K, Hashiguchi Y.
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R, Iinuma H, Dejima H, Sakai T, Uehara H, Matsutani N, Kawamura M.
    Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y, Iinuma H, Tsukamoto M, Matsuda K, Hashiguchi Y.
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
    Takahasi K, Iinuma H, Wada K, Minezaki S, Kawamura S, Kainuma M, Ikeda Y, Shibuya M, Miura F, Sano K.
    J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
    [Abstract] [Full Text] [Related]

  • 5. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A.
    Sci Rep; 2017 Mar 06; 7():43393. PubMed ID: 28262692
    [Abstract] [Full Text] [Related]

  • 6. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.
    Ann Surg; 2014 Apr 06; 259(4):735-43. PubMed ID: 23982750
    [Abstract] [Full Text] [Related]

  • 7. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland CR, Goel A.
    Gut; 2017 Apr 06; 66(4):654-665. PubMed ID: 26701878
    [Abstract] [Full Text] [Related]

  • 8. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
    Yan S, Jiang Y, Liang C, Cheng M, Jin C, Duan Q, Xu D, Yang L, Zhang X, Ren B, Jin P.
    J Cell Biochem; 2018 May 06; 119(5):4113-4119. PubMed ID: 29240249
    [Abstract] [Full Text] [Related]

  • 9. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H, Toiyama Y, Fujikawa H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Toden S, Goel A, Kusunoki M.
    Ann Oncol; 2016 Oct 06; 27(10):1879-86. PubMed ID: 27502702
    [Abstract] [Full Text] [Related]

  • 10. Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage.
    Kumata Y, Iinuma H, Suzuki Y, Tsukahara D, Midorikawa H, Igarashi Y, Soeda N, Kiyokawa T, Horikawa M, Fukushima R.
    Oncol Rep; 2018 Jul 06; 40(1):319-330. PubMed ID: 29749537
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J, Chen Y, Guo X, Zhou L, Jia Z, Tang Y, Lin L, Liu W, Ren C.
    Tumour Biol; 2016 Jul 06; 37(7):8765-73. PubMed ID: 26743779
    [Abstract] [Full Text] [Related]

  • 12. Examining plasma microRNA markers for colorectal cancer at different stages.
    Sun Y, Liu Y, Cogdell D, Calin GA, Sun B, Kopetz S, Hamilton SR, Zhang W.
    Oncotarget; 2016 Mar 08; 7(10):11434-49. PubMed ID: 26863633
    [Abstract] [Full Text] [Related]

  • 13. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
    Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, Doki Y, Mori M, Ochiya T, Mimori K.
    Br J Cancer; 2015 Jul 14; 113(2):275-81. PubMed ID: 26057451
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G, Wang R, Wang M.
    Cancer Biomark; 2019 Jul 14; 25(1):11-18. PubMed ID: 31006664
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N, Zhang PP, Huang JJ, Wang ZY, Zhang ZH, Yuan JZ, Ma EM, Liu X, Bai J.
    Eur Rev Med Pharmacol Sci; 2020 Jan 14; 24(2):664-672. PubMed ID: 32016967
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL, Chen YL, Ge ZZ, Qu YY, Cao Y, Kang ZX.
    Cancer Biomark; 2019 Jan 14; 26(1):69-77. PubMed ID: 31306108
    [Abstract] [Full Text] [Related]

  • 20. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H, Ghanadian S, Pakravan K, Razmara E, Rouhollah F, Mossahebi-Mohammadi M, Babashah S.
    Life Sci; 2020 Oct 01; 258():118226. PubMed ID: 32771555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.